Zhang, Qiang
Balourdas, Dimitrios-Ilias http://orcid.org/0000-0002-1790-2268
Baron, Bruno
Senitzki, Alon
Haran, Tali E. http://orcid.org/0000-0002-9700-3392
Wiman, Klas G. http://orcid.org/0000-0002-7113-524X
Soussi, Thierry http://orcid.org/0000-0001-8184-3293
Joerger, Andreas C. http://orcid.org/0000-0002-1232-0138
Funding for this research was provided by:
Israel Science Foundation (1517/14)
Cancerfonden
Deutsche Forschungsgemeinschaft (JO 1473/1-3)
Article History
Received: 2 December 2021
Revised: 8 February 2022
Accepted: 15 February 2022
First Online: 7 March 2022
Competing interests
: K.G.W. is co-founder and shareholder of Aprea Therapeutics, a company that develops p53-based cancer therapy, and is a member of its Clinical Advisory Board.